Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Waserman

Showing results (51-60 of 152) with videos related to

Pageof 16
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 28, 2012
Management of anaphylaxis in schools: Evaluation of an epinephrine auto-injector (EpiPen®) use by school personnel and comparison of two approaches of soliciting participationNha Uyen Nguyen Luu, Lisa Cicutto, Lianne Soller, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 8, 2010
Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI)Eric Leith, Tom Bowen, Joe Butchey, et al.
Allergy and Asthma Proceedings|January 31, 2023
Epinephrine autoinjectors: individualizing device and dosage to optimize anaphylaxis management in the community settingHarold Kim, Reza Alizadehfar, Waleed Alqurashi, et al.
Advances in Therapy|February 13, 2024
Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe AsthmaAndrea Bever, Jessica Dunne, Jenna Reynolds, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2020
Multidisciplinary Real-World Experience With Bilastine, a Second Generation AntihistamineCharles W. Lynde, Gordon Sussman, Pierre-Luc Dion, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 20, 2015
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitisHarold Kim, Susan Waserman, Jacques Hébert, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2009
Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactionsKatherine Arias, Moiz Baig, Marc Colangelo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 12, 2025
ALERT (ChAracterizing uncontroLled sevERe asThma in Canada): Oral corticosteroid and short-acting β<sub>2</sub>-agonist overuseAndréanne Côté, Jeffrey Beach, Jenna Reynolds, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 23, 2021
Demographic and clinical characteristics of patients with hereditary angioedema in CanadaErika Yue Lee, Jane Hsieh, Teresa Caballero, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 17, 2015
The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and childrenJacques Hébert, Michael Blaiss, Susan Waserman, et al.
Pageof 16

Showing results (51-60 of 152) with videos related to

Sort By:
Pageof 16
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 28, 2012
Management of anaphylaxis in schools: Evaluation of an epinephrine auto-injector (EpiPen®) use by school personnel and comparison of two approaches of soliciting participationNha Uyen Nguyen Luu, Lisa Cicutto, Lianne Soller, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 8, 2010
Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI)Eric Leith, Tom Bowen, Joe Butchey, et al.
Allergy and Asthma Proceedings|January 31, 2023
Epinephrine autoinjectors: individualizing device and dosage to optimize anaphylaxis management in the community settingHarold Kim, Reza Alizadehfar, Waleed Alqurashi, et al.
Advances in Therapy|February 13, 2024
Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe AsthmaAndrea Bever, Jessica Dunne, Jenna Reynolds, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2020
Multidisciplinary Real-World Experience With Bilastine, a Second Generation AntihistamineCharles W. Lynde, Gordon Sussman, Pierre-Luc Dion, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 20, 2015
Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitisHarold Kim, Susan Waserman, Jacques Hébert, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2009
Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactionsKatherine Arias, Moiz Baig, Marc Colangelo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 12, 2025
ALERT (ChAracterizing uncontroLled sevERe asThma in Canada): Oral corticosteroid and short-acting β<sub>2</sub>-agonist overuseAndréanne Côté, Jeffrey Beach, Jenna Reynolds, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 23, 2021
Demographic and clinical characteristics of patients with hereditary angioedema in CanadaErika Yue Lee, Jane Hsieh, Teresa Caballero, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 17, 2015
The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and childrenJacques Hébert, Michael Blaiss, Susan Waserman, et al.
Pageof 16